You are here Home Resources and guidance Sponsors Dr Falk Pharma Australia Pty Ltd Regulatory activities for this sponsor. Listen Print Share LinkedIn (Twitter) Facebook Email Loading... Type ARTG (1) Designation or determination (1) Date (-) 2021 (1) (-) 2019 (1) 2025 (4) 2024 (2) 2020 (1) 2018 (1) 2016 (2) 2014 (1) 2012 (2) 2010 (1) 2008 (1) 2007 (1) 2006 (2) 2004 (2) 2002 (4) 2000 (1) 1999 (1) Search Filters applied:20192021Clear all Sponsor content2 result(s) found, displaying 1 to 2 JORVEZA budesonide 0.5 mg orally disintegrating tablet blister pack (350996) 6 September 2021 ARTG Australian Register of Therapeutic Goods (ARTG) information for JORVEZA budesonide 0.5 mg orally disintegrating tablet blister pack. Notice for budesonide (Dr Falk Pharma Australia Pty Ltd) 20 June 2019 Designation or determination Orphan drug
JORVEZA budesonide 0.5 mg orally disintegrating tablet blister pack (350996) 6 September 2021 ARTG Australian Register of Therapeutic Goods (ARTG) information for JORVEZA budesonide 0.5 mg orally disintegrating tablet blister pack.
Notice for budesonide (Dr Falk Pharma Australia Pty Ltd) 20 June 2019 Designation or determination Orphan drug